Isomorphic Labs
Isomorphic Labs uses artificial intelligence to accelerate and improve drug discovery and medicine development. It builds computational biology platforms that model molecular and cellular mechanisms to identify and prioritize drug candidates. The company combines deep learning, structural biology models, large-scale biological datasets, and simulation to predict compound effects and generate insights for researchers. Isomorphic Labs operates as an AI-first commercial drug discovery platform serving pharmaceutical companies and research institutions. Its digital-biology approach supports scalable in-silico workflows to shorten R&D timelines and improve hit-finding efficiency.
Isomorphic Labs
Isomorphic Labs uses artificial intelligence to accelerate and improve drug discovery and medicine development. It builds computational biology platforms that model molecular and cellular mechanisms to identify and prioritize drug candidates. The company combines deep learning, structural biology models, large-scale biological datasets, and simulation to predict compound effects and generate insights for researchers. Isomorphic Labs operates as an AI-first commercial drug discovery platform serving pharmaceutical companies and research institutions. Its digital-biology approach supports scalable in-silico workflows to shorten R&D timelines and improve hit-finding efficiency.